Global PET-CT Scanner Device Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The Global PET-CT Scanner Device Market has been segmented by application into Oncology, Cardiology, Neurology, and Others, each representing a crucial area of medical imaging that benefits from PET-CT technology. Among these, oncology holds the largest market share due to the increasing prevalence of cancer worldwide. PET-CT scanners play a vital role in cancer diagnosis, staging, and monitoring treatment response, providing detailed metabolic and anatomical insights. The rising adoption of advanced imaging technologies, coupled with increasing investments in cancer research, is expected to drive the demand for PET-CT scanners in oncology applications.

Cardiology represents another significant segment, where PET-CT scanners are used for assessing myocardial perfusion, evaluating coronary artery disease, and detecting viable heart tissue. The ability of PET-CT to provide precise and early detection of cardiovascular conditions makes it a valuable tool in cardiology. With the growing burden of heart diseases globally, especially in aging populations, the demand for PET-CT in cardiology is expected to increase. Additionally, ongoing technological advancements in PET-CT imaging, including hybrid imaging techniques, are enhancing its application in cardiac diagnostics.

In the neurology segment, PET-CT scanners are widely used for diagnosing and monitoring neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and brain tumors. The high-resolution imaging capabilities of PET-CT allow for early detection of neurodegenerative diseases, aiding in timely intervention and treatment planning. The increasing prevalence of neurological disorders, particularly among the elderly, along with advancements in radiopharmaceuticals targeting neurological conditions, is expected to drive growth in this segment.

The Others segment includes applications such as infectious diseases, inflammatory conditions, and orthopedic imaging, where PET-CT is used for evaluating metabolic activity in tissues. The versatility of PET-CT scanners in diagnosing various medical conditions beyond oncology, cardiology, and neurology highlights their growing clinical significance. As research in new radiotracers and imaging protocols continues to expand, the application scope of PET-CT scanners is likely to widen, further driving market growth.

Global PET-CT Scanner Device Segment Analysis

In this report, the Global PET-CT Scanner Device Market has been segmented by Product Type, Detector Type, Setting, Application and Geography.

Global PET-CT Scanner Device Market, Segmentation by Product Type

The Global PET-CT Scanner Device Market has been segmented by Product Type into Stationary PET-CT Scanners, and Portable/Mobile PET-CT Scanners.

The Global PET-CT Scanner Device Market is segmented based on product type into Stationary PET-CT Scanners and Portable/Mobile PET-CT Scanners. This segmentation allows for a clearer understanding of the market dynamics, catering to different clinical and operational needs within the healthcare sector. Each category has distinct advantages, influencing adoption rates across hospitals, diagnostic centers, and research institutions.

Stationary PET-CT Scanners dominate the market due to their advanced imaging capabilities, higher resolution, and suitability for high-volume diagnostic centers. These scanners are typically installed in large hospitals and specialized imaging centers, where they provide high-quality imaging for oncology, cardiology, and neurology applications. The increasing prevalence of chronic diseases, coupled with technological advancements such as AI integration and improved detector systems, is driving the demand for stationary PET-CT scanners. However, their high cost and installation requirements may limit accessibility in smaller healthcare facilities.

On the other hand, Portable/Mobile PET-CT Scanners are gaining traction due to their flexibility and cost-effectiveness. These scanners are particularly beneficial for remote and underserved areas, allowing healthcare providers to offer diagnostic services without requiring extensive infrastructure. Mobile PET-CT scanners are also favored for military applications, field hospitals, and temporary medical camps. The rising demand for point-of-care diagnostics and the need for on-site imaging in non-traditional settings are key factors propelling the growth of this segment.

Overall, the segmentation of the PET-CT scanner market highlights the evolving needs of healthcare facilities and advancements in imaging technology. While stationary scanners remain the gold standard for precision diagnostics, mobile solutions are expanding access to critical imaging services. As the market continues to grow, innovations in scanner portability, image quality, and affordability will shape future adoption trends across various healthcare settings.

Global PET-CT Scanner Device Market, Segmentation by Detector Type

The Global PET-CT Scanner Device Market has been segmented by Detector Type into FluroDeoxyGlucose (FDG), 62CU ATSM, FMISO, Gallium, Thallium and Others.

The global PET-CT scanner device market is witnessing significant growth, driven by advancements in medical imaging technology and an increasing prevalence of chronic diseases such as cancer and cardiovascular disorders. One of the key segmentation factors shaping this market is the detector type used in PET-CT scanners. Among these detector types, FluroDeoxyGlucose (FDG) stands out as the most widely utilized, owing to its ability to detect glucose metabolism, particularly in cancerous cells. FDG-PET-CT imaging has become a cornerstone in oncology diagnostics, aiding in tumor detection, staging, and treatment response assessment.

In addition to FDG, other detector types such as 62CU ATSM, FMISO, Gallium, and Thallium cater to specific diagnostic needs. For instance, 62CU ATSM is particularly useful in imaging hypoxia, which is a common feature in solid tumors and can influence treatment strategies. FMISO, on the other hand, targets tissue hypoxia and is valuable in radiation therapy planning. Gallium and Thallium isotopes are utilized in certain specialized imaging procedures, offering insights into specific physiological processes or organs.

Ongoing research and development efforts are continuously expanding the applications of PET-CT imaging, driving demand for innovative detector technologies. The market for PET-CT scanner devices is expected to witness sustained growth as healthcare providers increasingly recognize the clinical utility of PET-CT imaging across a range of medical specialties. Additionally, with rising investments in healthcare infrastructure and the growing adoption of hybrid imaging techniques, particularly in emerging economies, the global PET-CT scanner device market is poised for further expansion in the coming years.

Global PET-CT Scanner Device Market, Segmentation by Setting

The Global PET-CT Scanner Device Market has been segmented by Setting into Fixed and Mobile.

The global PET-CT scanner device market continues to experience significant growth, driven by advances in medical imaging technology and an increasing prevalence of chronic diseases such as cancer. PET-CT scanners play a crucial role in diagnosing and monitoring various conditions by providing detailed anatomical and functional information simultaneously. The market segmentation by setting highlights two primary categories: fixed and mobile PET-CT scanners.

Fixed PET-CT scanners are typically installed in hospitals, imaging centers, and specialized medical facilities. These systems offer high-resolution imaging capabilities and are well-suited for routine diagnostic procedures and research applications. They provide healthcare professionals with comprehensive data for accurate diagnosis and treatment planning. The demand for fixed PET-CT scanners is sustained by the growing need for advanced imaging solutions in established healthcare settings.

Mobile PET-CT scanners are gaining traction due to their flexibility and accessibility. These units can be transported to different locations, including remote areas, outpatient clinics, and temporary medical facilities. Mobile PET-CT scanners enable healthcare providers to extend imaging services to underserved regions, improving patient access to diagnostic capabilities. Additionally, they are often deployed for specialized medical missions, disaster response efforts, and clinical trials.

Global PET-CT Scanner Device Market, Segmentation by Application

The Global PET-CT Scanner Device Market has been segmented by Application into Oncology, Cardiology, Neurology, and Others.

Global PET-CT Scanner Device Market, Segmentation by Geography

In this report, the Global PET-CT Scanner Device Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global PET-CT Scanner Device Market Share (%), by Geographical Region, 2024

The global PET-CT scanner device market is experiencing steady growth and is segmented by geography into five key regions: North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America holds a significant share of the market, driven by technological advancements, high healthcare expenditure, and increasing prevalence of chronic diseases like cancer. Moreover, favorable reimbursement policies and early adoption of advanced medical technologies further boost market growth in this region.

Europe is also a prominent market for PET-CT scanner devices, propelled by increasing healthcare infrastructure development, rising demand for non-invasive diagnostic techniques, and growing awareness regarding early disease detection. Additionally, collaborations between research institutions and healthcare facilities for clinical research studies contribute to the market expansion in Europe.

The Asia Pacific region is witnessing rapid growth in the PET-CT scanner device market due to rising healthcare expenditure, improving healthcare infrastructure, and growing awareness about the benefits of early disease diagnosis. Countries like China and India are emerging as lucrative markets for PET-CT scanner devices owing to large patient populations and increasing government initiatives to enhance healthcare accessibility and affordability.

In the Middle East and Africa region, the market for PET-CT scanner devices is driven by improving healthcare infrastructure, rising investments in healthcare facilities, and increasing prevalence of chronic diseases. Moreover, initiatives by governments and healthcare organizations to upgrade medical facilities and enhance diagnostic capabilities further fuel market growth in this region.

Latin America also presents significant opportunities for the PET-CT scanner device market, supported by increasing healthcare spending, growing medical tourism, and rising prevalence of chronic diseases. Additionally, government initiatives to improve healthcare infrastructure and expand access to advanced medical technologies contribute to the market's growth trajectory in Latin America.

This report provides an in depth analysis of various factors that impact the dynamics of Global PET-CT Scanner Device Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers:

• Technological advancements in imaging
• Growing prevalence of cancer
• Increasing demand for early diagnosis
• Rising healthcare expenditure

• Favorable reimbursement policies: The global PET-CT scanner device market has witnessed significant growth in recent years, driven by several factors, including favorable reimbursement policies. PET-CT scanners play a crucial role in diagnosing and monitoring various medical conditions, particularly cancer. With the increasing prevalence of cancer worldwide and the growing demand for accurate diagnostic tools, the demand for PET-CT scanners has surged. Favorable reimbursement policies implemented by governments and healthcare organizations have further fueled market growth by making these expensive imaging procedures more accessible to patients. Additionally, advancements in technology have led to the development of more efficient and user-friendly PET-CT scanners, enhancing their adoption across healthcare facilities globally.

  The market for PET-CT scanner devices is expected to continue its upward trajectory as healthcare systems increasingly prioritize early detection and personalized treatment approaches. The integration of artificial intelligence (AI) and machine learning algorithms into PET-CT imaging processes has also contributed to market expansion by improving diagnostic accuracy and efficiency. Furthermore, rising investments in healthcare infrastructure in emerging economies, coupled with growing awareness about the benefits of early disease detection, are anticipated to drive further market growth. Overall, with favorable reimbursement policies and technological advancements driving accessibility and accuracy, the global PET-CT scanner device market is poised for continued expansion in the foreseeable future.

Restraints:

• High initial investment costs
• Limited accessibility in rural areas
• Concerns regarding radiation exposure
• Regulatory challenges

• Competition from alternative imaging modalities: The global PET-CT scanner device market continues to face increasing competition from alternative imaging modalities, posing challenges and opportunities for industry players. While PET-CT technology has long been a cornerstone in oncology, neurology, and cardiology diagnostics due to its ability to provide both anatomical and functional information, alternative modalities such as MRI and advanced ultrasound technologies are gaining traction. These alternatives offer advantages such as higher resolution imaging, reduced radiation exposure, and improved soft tissue differentiation, presenting a compelling value proposition for clinicians and patients alike.

  As a response to this evolving landscape, market players in the PET-CT scanner industry are focusing on innovation and differentiation to maintain their competitive edge. This includes advancements in PET-CT technology to enhance image quality, reduce scan times, and expand clinical applications. Additionally, strategic collaborations with healthcare providers and research institutions are being forged to drive adoption and demonstrate the value of PET-CT in complementing other imaging modalities. While challenges persist in terms of reimbursement issues and cost constraints, the PET-CT scanner market remains dynamic, with opportunities for growth fueled by ongoing technological advancements and increasing demand for personalized medicine approaches.

Opportunities:

• Expansion in emerging markets
• Development of portable devices
• Integration with AI technology
• Rising awareness campaigns

• Collaborations for research and development: Collaborations in research and development within the global PET-CT scanner device market have become increasingly vital for driving innovation and meeting evolving healthcare needs. With the complexity of technology and the demand for advanced imaging capabilities rising, partnerships between medical device manufacturers, research institutions, and healthcare providers have emerged as a strategic approach to address challenges and capitalize on opportunities. These collaborations often leverage diverse expertise and resources to enhance product development, optimize manufacturing processes, and explore novel applications for PET-CT technology. By pooling knowledge and resources, collaborators can accelerate the pace of innovation, reduce development costs, and ultimately deliver more effective and accessible imaging solutions to healthcare providers and patients worldwide.

  Collaborations in research and development within the global PET-CT scanner device market are also crucial for advancing clinical research and improving patient outcomes. Through partnerships between medical device companies, academic institutions, and clinical research organizations, stakeholders can access diverse patient populations, clinical expertise, and data resources to conduct rigorous studies and validate the efficacy of PET-CT imaging in diagnosing and monitoring various diseases. These collaborations facilitate the translation of scientific discoveries into clinical practice, driving the adoption of PET-CT technology for early detection, accurate staging, and personalized treatment planning across a range of medical specialties. Additionally, collaborative research efforts enable the development of standardized protocols, quality assurance measures, and regulatory guidelines to ensure the safety, efficacy, and reliability of PET-CT imaging in diverse clinical settings, ultimately benefiting healthcare providers, researchers, and patients worldwide.

Key players in Global PET-CT Scanner Device Market include:

• General Electric Co
• Hitachi, Ltd.
• Mediso Ltd.
• Koninklijke Philips N.V.
• PerkinElmer, Inc.
• Positron Corporation
• Siemens AG
• Shimadzu Corporation

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis